AB AB Science S.A.

0.6230USD0.5680 EUR · EPA-0.87%Mkt Cap: 59.61M USDP/E: —

AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…

Institutional holders1 on file

Key Statistics

Company
Market Cap59.61M USD
Enterprise Value59.52M USD
Revenue (TTM)1.27M USD
Gross Profit1.07M USD
Net Income (TTM)-1.71M USD
Revenue/Share0.02 USD
Last Price0.6230 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0010557264
Valuation
P/E (Trailing)—
P/E (Forward)-4.02
PEG—
EV/EBITDA-7.76
EV/Revenue46.91
P/S46.97
P/B-1.92
EPS (TTM)-0.08 USD
EPS (Forward)-0.15 USD
52W Range
0.53527% of range1.766
52W High1.766 USD
52W Low0.5352 USD
Profitability
Gross Margin83.30%
Oper. Margin-608.90%
EBITDA Margin0.00%
Profit Margin-132.62%
ROE9.05%
ROA-6.35%
ROIC—
ROCE6.58%
Growth
Revenue Growth-3.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.70M USD
CapEx (TTM)309.30K USD
FCF Margin-301.37%
FCF Yield-6.42%
Net Debt12.25M USD
Net Debt/EBITDA-1.60
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.10
Current Ratio0.85
Quick Ratio0.78
Book Value/Sh-0.32 USD
Cash/Share0.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.96.53M
Float18.96M
Insiders47.71%
Institutions0.00%
Technical
SMA 500.6510 (-4.3%)
SMA 2000.9547 (-34.7%)
Beta1.24
S&P 52W Chg12.00%
Avg Vol (30d)189.10K
Avg Vol (10d)354.87K
Technical Indicators
RSI (14)49.4
MACD0.0026
MACD Signal-0.0037
MACD Hist.+0.0063
BB Upper0.6997 USD
BB Middle0.6098 USD
BB Lower0.5199 USD
BB Width29.48%
ATR (14)0.0389 USD
Vol Ratio (20d)0.13x

About AB Science (EPA: AB)

›

AB Science (EPA: AB) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 33 employees.

The shares were at 0.5680 EUR on 19 November 2026, down 50.6% over 52 weeks. Its 52-week range is 0.4880 EUR to 1.610 EUR: the price is 64.7% below the high and 16.4% above the low.

Its market capitalisation is 54.35M EUR.

AB Science reports return on equity of 9.1% and revenue down 3.3% year over year.

Its debt exceeds its cash by 11.17M EUR. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.